These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29122635)

  • 21. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do the types and routes of proton pump inhibitor treatments affect
    Lee P; Fike D; Yang H; Hall RG; Pass S; Alvarez CA
    Expert Rev Clin Pharmacol; 2021 Mar; 14(3):399-404. PubMed ID: 33576287
    [No Abstract]   [Full Text] [Related]  

  • 23. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
    Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional differences in Clostridium difficile infections in relation to fluoroquinolone and proton pump inhibitor use, Finland, 2008-2011.
    Kanerva M; Ollgren J; Voipio T; Mentula S; Lyytikäinen O
    Infect Dis (Lond); 2015 Aug; 47(8):530-5. PubMed ID: 25832317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System.
    Watson T; Hickok J; Fraker S; Korwek K; Poland RE; Septimus E
    Clin Infect Dis; 2018 Jun; 66(12):1957-1959. PubMed ID: 29272341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and molecular characteristics of community-acquired Clostridium difficile infections in comparison with those of hospital-acquired C. difficile.
    Kwon SS; Gim JL; Kim MS; Kim H; Choi JY; Yong D; Lee K
    Anaerobe; 2017 Dec; 48():42-46. PubMed ID: 28655581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
    Thabit AK; Housman ST; Burnham CD; Nicolau DP
    J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors for hospital-acquired Clostridium difficile infection among inpatients in an orthopaedic tertiary care hospital.
    Campbell KA; Phillips MS; Stachel A; Bosco JA; Mehta SA
    J Hosp Infect; 2013 Feb; 83(2):146-9. PubMed ID: 23313026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.
    Biswal S
    Biomed J; 2014; 37(4):178-83. PubMed ID: 25116712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.
    Roughead EE; Chan EW; Choi NK; Griffiths J; Jin XM; Lee J; Kimura M; Kimura T; Kubota K; Lai EC; Man KK; Nguyen TA; Ooba N; Park BJ; Sato T; Shin JY; Wang T; Wong IC; Yang YK; Pratt NL
    Expert Opin Drug Saf; 2016 Dec; 15(12):1589-1595. PubMed ID: 27645304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inappropriate prescribing of proton pump inhibitors in hospitalized patients.
    Reid M; Keniston A; Heller JC; Miller M; Medvedev S; Albert RK
    J Hosp Med; 2012; 7(5):421-5. PubMed ID: 22190465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection.
    Cao F; Chen CX; Wang M; Liao HR; Wang MX; Hua SZ; Huang B; Xiong Y; Zhang JY; Xu YL
    J Hosp Infect; 2018 Jan; 98(1):4-13. PubMed ID: 28842261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community-acquired Clostridium difficile infections in emergency departments.
    Lefevre-Tantet-Etchebarne D; Sivadon-Tardy V; Davido B; Bouchand F; Grenet J; Farfour E; Getti R; Duran C; Chéron M; Mathieu E; Salomon J; Dinh A
    Med Mal Infect; 2016 Oct; 46(7):372-379. PubMed ID: 27377443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
    Dial S; Delaney JA; Barkun AN; Suissa S
    JAMA; 2005 Dec; 294(23):2989-95. PubMed ID: 16414946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitors: Clostridium difficile infections.
    Prescrire Int; 2013 Oct; 22(142):239-40. PubMed ID: 24298587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reply to Wiegand et al.: proton pump inhibitor over-use and the ongoing battle to control Clostridium difficile infection in hospitals.
    Goyder A; Herbert R
    J Hosp Infect; 2013 Jun; 84(2):188. PubMed ID: 23639818
    [No Abstract]   [Full Text] [Related]  

  • 40. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
    Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
    J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.